ME-3183
- Generic Name
- ME-3183
Efficacy and Safety of ME3183 in Subjects With Moderate to Severe Plaque Psoriasis
- First Posted Date
- 2022-03-07
- Last Posted Date
- 2024-06-27
- Lead Sponsor
- Meiji Pharma USA Inc.
- Target Recruit Count
- 132
- Registration Number
- NCT05268016
- Locations
- 🇨🇦
SKiN Health, Cobourg, Ontario, Canada
🇨🇦The Centre for Dermatology, Richmond Hill, Ontario, Canada
🇨🇦Toronto Research Centre, Toronto, Ontario, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath